ReviewJournal of clinical medicine2023
Refractory Takayasu's Arteritis with Severe Coronary Involvement-Case Report and Literature Review.
Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Could Skin Autofluorescence Be a Useful Biomarker in Systemic Lupus Erythematosus? A Systematic Review.International journal of molecular sciences · 2025Pooled it
- Diffuse Pericoronary Soft-Tissue Cuffing on Coronary Computed Tomography Angiography in a Patient with Unstable Angina: Possible IgG4-Related Coronary Periarteritis.Diagnostics (Basel, Switzerland) · 2026Article
- Cardiac arrest as the first presentation of Takayasu arteritis in a young adult: a case report.European heart journal. Case reports · 2026Article
- Takayasu Arteritis-Induced Acute Myocardial Infarction: Coronary Imaging- and Physiology-Guided Management.JACC. Case reports · 2026Article
- Prevalence and characteristics of coronary arteritis within a prospective observational cohort of patients with Takayasu's arteritis.Frontiers in immunology · 2026Observational
- Translating Guidelines into Practice: A Prospective Real-World Study of a Romanian Cohort Treated with GLP-1 RAs.Biomedicines · 2025Article
- CD8 cell-derived granzyme B may be a predictor for coronary artery involvement and MACE in Takayasu arteritis patients.Clinical and experimental immunology · 2025Article
- Etiology and prognosis of non-Kawasaki disease induced coronary aneurysms in children: a retrospective case series study.European journal of pediatrics · 2024Article
- STEMI Following In-Stent Restenosis in Coronary Takayasu Arteritis With Pyoderma Gangrenosum in a Teenaged Athlete.JACC. Case reports · 2024Article
- Current Perspectives in Giant Cell Arteritis: Can We Better Connect Pathogenesis and Treatment?Medicina (Kaunas, Lithuania) · 2024Review
- Coronary artery lesions in Takayasu arteritis.Reumatologia · 2023Review
- Coronary Vasculitis in Takayasu's: A Case Report and Review of the Literature on Optimal Surgical Intervention.Journal of investigative medicine high impact case reportsReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report presents the case of a female patient diagnosed with Takayasu arteritis from childhood, with severe, refractory coronary involvement, leading to two acute coronary syndromes and multiple anginous episodes. Consequently, the patient suffered aorto-bicarotid bypass two times, multiple interventional procedures with stent implantation, balloon angioplasty, and up to ten repeated in-stent restenosis that required reinterventions, despite being on maximal immunosuppressive treatment. In recent years, various studies have been reported that aim to best characterize this particular type of vascular damage and to indicate optimal therapeutic options for treatment. The latter should be based on the activity of the underlying disease; however, no reliable markers are available in TA. The management of TA patients with coronary involvement continues to be a challenge and requires both drug and interventional techniques to avoid life-threatening events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.